PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diagnostic Support, Science Group, UK Health Security Agency, Porton, Porton Down, United Kingdom.\', \'SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton, Porton Down, United Kingdom.\', \'Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton, Porton Down, United Kingdom.\', \'NHS Blood and Transfusion, Microbiology Services, Colindale, United Kingdom.\', \'UK Health Security Agency, Colindale, United Kingdom.\', \'Seroepidemiology Unit, UK Health Security Agency, Manchester, United Kingdom.\', \'Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.\', \'Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.\', \'Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.\', \'Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.\', \'UK Health Security Agency (UKHSA), Porton, Porton Down, United Kingdom.\', \'Pathogen Immunology, UK Health Security Agency (UKHSA), Porton, Porton Down, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/spectrum.02289-21
?:doi
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 35196807
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
?:title
  • Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom\'s COVID-19 Public Health Response.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all